Professor Jacobson and Hanna Liu, MD/MBA '16, co-authored this post on how building on existing data sources could create a richer, more complete understanding of current drug shortages. In 2012, over 80 percent of presecription drug shortages in the U.S. were generic and many were commonly used as anti-infective, anesthesia, and chemotherapy agents. Read more.
Professor Jacobson was interviewed regarding an NBER working paper she has co-authored titled, "Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers?" The study authors examined admissions to substance abuse treatment programs for opiate addiction as well as opiate overdose deaths in states that do and do not have medical marijuana laws. According to Jacobson, "Some people who would have dealt with their pain through the use of opioids may now be opting to use medical marijuana in states allowing it." Read more.
With fewer private health insurers and rising rates, some say we will regret not having a public option as part of the mix. Dr. Mireille Jacobson, Center Director and Associate Professor, was interviewed on how the benefits of another insurance option would have made private insurers reluctant to raise rates. Read more.
Core Center Faculty member Dr. Zeev Kain, department chair of anesthesiology at UCI, on a patient-centric approach to standardize care and reduce system-related variability throughout the entire surgical journey. This article addresses a team approach, from the minute the surgeon and the patient decide a procedure is needed until 30 days after discharge. Read more.
The Kansas City area is experiencing bumper-to-bumper developments in its cancer care marketplace. In this article Dr. Mireille Jacobson, Center Director and Associate Professor, discusses the payment method to reimburse physicians administering outpatient chemotherapy drugs. Read more.
American businesses are facing evolving policies, new market forces, and an unprecedented era of consumerism in health care. The ACA touches every employer and employee, and health care remains a huge economic force of the U.S. economy. Click here to readd seven trends every business leader needs to understand by by Advisory Board member Murray Ross, Ph.D
Advisory Board member, Murray Ross, Ph.D., co-authored this post on the Health Affairs blog post on overdose from prescription painkillersis. The epidemic is on the rise, as deaths have more than quadrupled in the past decade and a half. Today, more people die from prescription opioid overdose than from heroin, cocaine, and all other drugs combined. Kaiser Permanente’s approach includes seven “levers” to address the problem from multiple angles. Click here to read more.
Who hasn’t experienced fear? This is a part of life no matter if you are at the top of your medical career or just starting on your journey. Most cases of physician burnout are rooted in depression and isolation resulting in withdrawal of the physician from remaining connected and engaged with friends, colleagues and loved one. Advisory Board member Robert Beltran, MD, MBA outlines six attributes of courage to face fear and avoid burnout. Read more.
Join us this February 23-24, 2017 for our annual health care forecast conference.
Join us Friday, October 21 for our fall speaker series that will address Value Based Pharmaceutical Contracts. Keynote Speaker is Michael Sherman, MD, Senior Vice President and Chief Medical Officer, Harvard Pilgrim Health Care.
The Center supports the Paul Merage School of Business MBA programs by helping to merge the medical and health care industries with business education in a unique learning environment. We are among a small group of elite institutions that offer a combined MD/MBA program that attracts candidates with a unique interest in the business of medicine. Additionally, over 10% of Fully Employed MBA students work in health care, and nearly 10% of our Full Time MBA students seek employment in the health care industry upon graduation.
If you are a current student, consider joining the Merage Healthcare Association for the latest student-focused industry events.